Tag: JIA

Early Combined Treatment with Biologic and Conventional DMARDs Could be Effective for Polyarticular Juvenile Arthritis

sarah JonasResearch Results

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, found that patients started on early, aggressive treatment with a combination of biologic and conventional disease modifying antirheumatic drugs (DMARDs) achieved clinically inactive disease in children with polyarticular juvenile idiopathic arthritis (JIA) more frequently compared to other treatment plans 24 months after starting treatment.